SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-095018
Filing Date
2023-08-24
Accepted
2023-08-24 21:50:45
Documents
2
Period of Report
2023-08-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2324788-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2324788-5_4seq1.xml 4 6035
2 EXHIBIT 24 tm2324788d5_ex24.htm EX-24 10239
  Complete submission text file 0001104659-23-095018.txt   17653
Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Peters Richard (Reporting) CIK: 0001697628 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 231203709

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 267-370-5219
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations